[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362362-105":59,"doc-detail-362362-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-p53-r181c-mutation-accumulates-through-impaired-deacetylation-by-sirt1-and-facilitates-tumor-development","The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development","","Li-Fraumeni Syndrome (LFS) links early-onset familial cancers to p53 mutations, and p53R181C is among the earliest described variants for hereditary breast cancer. This study shows that the p53 R181C mutation weakens p53 interaction with the Sirt1 deacetylase, elevating p53 K382 acetylation and suppressing MDM2-mediated ubiquitination and degradation. The mutation drives transcriptional loss of tumor-suppressor programs and gain of tumor-promoting signaling, promoting genomic instability and enabling tumor development. Overall, the work clarifies how p53R181C accumulates and advances cancer.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-p53-r181c-mutation-accumulates-through-impaired-deacetylation-by-sirt1-and-facilitates-tumor-development/362362/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-p53-r181c-mutation-accumulates-through-impaired-deacetylation-by-sirt1-and-facilitates-tumor-development/362362.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the p53 R181C mutation affect p53 regulation by Sirt1 and MDM2?","Question",{"text":113,"@type":114},"The p53 R181C mutation decreases p53 interaction with the Sirt1 deacetylase. This results in increased p53 K382 acetylation and inhibition of MDM2-mediated ubiquitination and degradation of p53.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What transcriptional changes are driven by the p53 R181C mutation?",{"text":118,"@type":114},"It causes loss-of-function for transcriptional regulation of tumor suppressor genes such as p21, bax, and PUMA. It also produces gain-of-function for tumor-promoting genes including PIK3CA, SHC1, SRC, and PAK4.",{"name":120,"@type":111,"acceptedAnswer":121},"Why does p53 R181C accumulation facilitate tumor development?",{"text":122,"@type":114},"The dysregulation promotes genomic instability, allowing cancer cells to evade cell-cycle control, senescence, and apoptosis. These changes together support tumor initiation and progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},362362,1790541736,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","communications biology Article  \n\n| A Nature Portfolio journal |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s42003-025-09465-y](https://doi.org/10.1038/s42003-025-09465-y) |  |  |\n| The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development\u003Cbr> Check for updates |  |  |\n| Erli Wang1,2,7, Liangzi Cao1,2,7, Wendong Guo1,2, Xiang Dong1,2, Wanying Zhang1,2, Xiaowen Zhang1,2, Zhuo Wang1,2, Xia Chen1,2, Aicun Li1,2, Yu Zou1,2, Shikun Li1,2, Kedian Chen1,2, Han Su1,2, Sunrun Cao1,2, Ning Du1,2, Pingyuan Wang3, Paul M. Hwang 3, Xiangsheng Liu 4 , Xiaoyu Song 1,2 , Hongde Xu 1,2 , Jingwei Liu  1,2  & Liu Cao  1,2,5,6  |  |  |\n| Li-Fraumeni Syndrome (LFS) is linked to mutations in the p53 gene and is characterized by autosomal dominant early-onset familial cancer susceptibility. The p53R181C mutation is one of the earliest described mutations associated with early-onset familial hereditary breast cancer. Highly stable mutant p53 protein is often a prerequisite for tumor initiation and progression, but the pathways leading to p53R181C accumulation and carcinogenesis are not understood. Here, we found that p53 R181C mutation decreases the interaction of p53with theSirt1deacetylase, resulting in increased p53 K382 acetylation and inhibition of MDM2-mediated ubiquitination and degradation of p53 . Moreover, the R181C mutation leads to “loss-of-function” of transcriptional regulating tumor suppressor genes like p21 , bax, and PUMA as well as “gain-of-function” of transcriptional regulating tumor promoting genes of PIK3CA, SHC1 , SRC and PAK4 . This dysregulation promotes genomic instability, enabling cancer cells to evade cell cycle control, senescence and apoptosis, thus facilitating tumor development. Our ﬁndings unraveled the mechanism by which the p53R181C mutant protein accumulates and facilitates tumor development. |  |  |\n| The p53 protein, known as the “guardian of the genome”, is a transcription factor that regulates cell fate by activating the expression of various target genes. It plays a crucial role in maintaining cellular homeostasis and genomic stability by participating in processes such as apoptosis and cell cycle arrest1,2. Mutations in p53 are common in tumor tissues, with a frequency of over 50%3, the mutations can lead to changes in the structure of the p53 protein, which may ultimately affect its ability to interact with MDM2 in speciﬁc regions4. Consequently, mutated p53 is incapable of initiating MDM2-mediated degradation, resulting in a decreased capacity to degrade mutated p53 itself. This widely-held concept has been widely regarded as the main mechanism responsible for the accumulation of mutated p53 protein in tumors5. The MDM2 variant | can also facilitate the accumulation of mutp53 and promote tumor development by inhibiting the degradation of mutp53 protein mediated by MDM26. Additionally, members of the heat shock protein family, such as Hsp90, can interact with mutp53, inhibiting its ubiquitination and degradation7. p53 mutations have been found to be signiﬁcant in the development and progression of tumors8. Most of them are missense mutations that occur within the DNA-binding domain9. These mutations cause the p53 protein to lose its tumor-suppressive function or acquire new pro-tumorigenic activities, contributing to tumor development, proliferation, migration, and drug resistance processes10. Furthermore, TP53 mutations in individuals with Li-Fraumeni syndrome can enhance oxidative metabolism through mitochondria in a cell-autonomous |  |\n\n1Clinical Translational Research Center, Shengjing Hospital, Health Sciences Institute, China Medical University, Shenyang, Liaoning Province, China. 2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors (China Medical University), Ministry of Education, Liaoning","cbCailVCm3Q711E6","https://ap.wps.com/l/cbCailVCm3Q711E6","pdf",4590639,14,"English","# Background\n## p53 mutations and tumor accumulation\n# Mechanistic findings\n## Sirt1 interaction and p53 acetylation\n## Effects on transcriptional regulation\n# Impact on tumor development\n## Genomic instability and evasion of cell fate","[{\"question\":\"How does the p53 R181C mutation affect p53 regulation by Sirt1 and MDM2?\",\"answer\":\"The p53 R181C mutation decreases p53 interaction with the Sirt1 deacetylase. This results in increased p53 K382 acetylation and inhibition of MDM2-mediated ubiquitination and degradation of p53.\"},{\"question\":\"What transcriptional changes are driven by the p53 R181C mutation?\",\"answer\":\"It causes loss-of-function for transcriptional regulation of tumor suppressor genes such as p21, bax, and PUMA. It also produces gain-of-function for tumor-promoting genes including PIK3CA, SHC1, SRC, and PAK4.\"},{\"question\":\"Why does p53 R181C accumulation facilitate tumor development?\",\"answer\":\"The dysregulation promotes genomic instability, allowing cancer cells to evade cell-cycle control, senescence, and apoptosis. These changes together support tumor initiation and progression.\"}]","The p53 R181C mutation accumulates through impaired deacetylation by Sirt1 and facilitates tumor development | PDF",1790147341,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0ae42743d0b717ccfcec692e1652d3c.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bab07dc296b9f3959a560b9881415d5e.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cab1417bf1bbb75c0bac6b277098e55a.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69a044d37392e35eefa66057e05898bf.webp",980,1301]